Capital Community College's vision is to instill life-changing knowledge in a community of learners from multicultural backgrounds in a vital urban setting where business, culture and government converge. This is a forum that presents news and information about training in Biotechnology at Capital .
Labels
- COMPANIES (7)
- COURSES (7)
- Inquiry Exercises (11)
- JOBS (8)
- METHODS (13)
- NEWS (35)
- STUDENT FORUM (2)
Showing posts with label JOBS. Show all posts
Showing posts with label JOBS. Show all posts
Tuesday, February 11, 2014
Looking for a Summer Biotech internship ?
A very useful compilation of summer Biotech internships.
Tuesday, January 14, 2014
Alexion increasing Drug Portfolio
Alexion Pharmaceuticals, buys new drug therapies from Moderna Therapeutics
Tuesday, June 25, 2013
CT's Alexion is one of the Three Best-run Biotechnology Companies in the USA !
Alexion was recently written up as one of the three best-run Biotechnology companies in the USA .
"Alexion's focus on ultra-rare diseases has led to ultra-rare results. The biotech achieved a 15.1% ROIC over the past year. Its five-year average of 21.6% is even better.
Earnings growth has been stellar. Alexion's net income over a trailing 12-month window increased 49% during the last year. Over the past five years, Alexion saw earnings skyrocket by more than 460%.
The company's CEO, Dr. Leonard Bell, helped develop Soliris, which treats the rare diseases paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Bell co-founded Alexion in 1992 and led the company through its IPO four years later. He also was instrumental in Alexion gaining regulatory approval for Soliris and successfully launching the drug. Along the way, Alexion has received several honors, including being named the world's second-most innovative company by Forbes in 2012. "
"Alexion's focus on ultra-rare diseases has led to ultra-rare results. The biotech achieved a 15.1% ROIC over the past year. Its five-year average of 21.6% is even better.
Earnings growth has been stellar. Alexion's net income over a trailing 12-month window increased 49% during the last year. Over the past five years, Alexion saw earnings skyrocket by more than 460%.
The company's CEO, Dr. Leonard Bell, helped develop Soliris, which treats the rare diseases paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Bell co-founded Alexion in 1992 and led the company through its IPO four years later. He also was instrumental in Alexion gaining regulatory approval for Soliris and successfully launching the drug. Along the way, Alexion has received several honors, including being named the world's second-most innovative company by Forbes in 2012. "
Monday, June 24, 2013
The Origin of GENENTECH
A very interesting reflection on GENENTECH, one of the original Biotechnology companies.
Jobs in Academic Research Labs
Biotechnology graduates typically look for jobs with large Biotechnology companies and are generally unaware of the excellent career development possibilities presented by small academic research labs. In small academic research labs, there is often a more significant focus on discovering new technologies that are yet to be found in mainstream Biotechnology. Thus, employment in an academic research lab often significantly enhances the career trajectory of Biotechnologists. In this post , we report the recent round of Stem Cell funding in CT, which will likely have the effect of increasing the number of entry level positions in academic Biotechnology labs.
"Nine scientists at the University of Connecticut Health Center received grant awards Monday totaling $4.5 million from the Connecticut Stem Cell Research Program, making UConn the largest recipient of the $9.8 million total grants awarded this year."
"Nine scientists at the University of Connecticut Health Center received grant awards Monday totaling $4.5 million from the Connecticut Stem Cell Research Program, making UConn the largest recipient of the $9.8 million total grants awarded this year."
Wednesday, June 19, 2013
What do biotechnology graduates get paid ?
What do biotechnology graduates get paid in California? CA Community Colleges publish salary info for different degrees.
Tuesday, June 18, 2013
New complex to be built by Alexion in New Haven may generate 200-300 Biotech Jobs
"Dr. Leonard Bell, founder and chief executive officer of Alexion, who
heads a company with a presence in 30 countries, said he expects New
Haven will become a major bio-pharmaceutical hub and drive economic
growth here and elsewhere in Connecticut"
"The state has agreed to provide $51 million in assistance if Alexion generates 200 to 300 more full-time jobs by 2017, in addition to the 350 it will bring to the city in its move from Cheshire."
"U.S. Sen. Richard Blumenthal, D-Conn., said the groundbreaking is also “a celebration of individual daring and risk taking and adventure ... It’s because of people like Lenny Bell that the American economy and America itself are the greatest in the world. Risk-takers and the scientists who invest of themselves in new enterprises are what ultimately will distinguish our nation on the world scene."
"The state has agreed to provide $51 million in assistance if Alexion generates 200 to 300 more full-time jobs by 2017, in addition to the 350 it will bring to the city in its move from Cheshire."
"U.S. Sen. Richard Blumenthal, D-Conn., said the groundbreaking is also “a celebration of individual daring and risk taking and adventure ... It’s because of people like Lenny Bell that the American economy and America itself are the greatest in the world. Risk-takers and the scientists who invest of themselves in new enterprises are what ultimately will distinguish our nation on the world scene."
Tuesday, June 11, 2013
50% of STEM jobs do not require a degree from a four year College !
A recent Brooking report indicates that 50% of STEM jobs do not require a degree from a four year College
and these jobs pay $53,000 on average.
Subscribe to:
Posts (Atom)